Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

14.66 +0.30 (+2.09%)

Streaming Delayed Price Updated: 3:35 PM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

February 22, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)

February 22, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Shareholder Alert: Robbins LLP Reminds Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders

February 21, 2022

From Robbins LLP

Via Business Wire

PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

February 21, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

February 21, 2022

From The Schall Law Firm

Via Business Wire

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

February 18, 2022

From The Schall Law Firm

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders

February 18, 2022

From Robbins LLP

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE

February 18, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm

February 17, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE

February 17, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors

February 17, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors

February 17, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.

February 17, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer

February 15, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 14, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 14, 2022

From Law Offices of Howard G. Smith

Via Business Wire

PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm

February 13, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm

February 11, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 11, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 10, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266....

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

February 10, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

February 09, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

51 Biggest Movers From Yesterday ↗

February 09, 2022

Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge ↗

February 08, 2022

US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday.

Via Benzinga

The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

What Is Happening With Pulse Biosciences Stock Today? ↗

February 08, 2022

Pulse Biosciences Inc (NASDAQ: PLSE) shares are tumbling after announcing an update to its recent FDA 510(k) submission to add sebaceous hyperplasia to expand the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 08, 2022

Gainers BioCardia (NASDAQ:BCDA) stock inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 08, 2022

Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

All News about Pulse Biosciences, Inc - Common Stock